Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study
NCT01261169 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2010-12-16
Summary
This study is designed to explore the use of Myfortic® in patients with steroid-refractory uveitis. The aim of the study will be to show the therapeutic effect of Myfortic® in managing uveitis patients.
Conditions
- Uveitis
Interventions
- DRUG
-
Myfortic
Myfortic in uveitis
Sponsors & Collaborators
- collaborator INDUSTRY
-
Genovate Biotechnology Co., Ltd.,
lead INDUSTRY
Principal Investigators
-
Hwang Yih Shiou, MD · CGMH
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Completion
- 2011-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis
NCT01900431 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab in Patients With Active Uveitis
NCT01138657 ·Status: COMPLETED ·Phase: PHASE3
-
Ustekinumab for Active Sight-Threatening Uveitis
NCT01647152 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of AIN457 in Noninfectious Uveitis
NCT00685399 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
NCT00826618 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
NCT00058994 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
NCT00468871 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uveitis
NCT04798755 ·Status: UNKNOWN ·Phase: PHASE3
-
Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
NCT06085079 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
NCT00006188 ·Status: COMPLETED
-
Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study
NCT01164085 ·Status: COMPLETED ·Phase: PHASE1
-
Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
NCT00043667 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
NCT03066869 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
NCT00855608 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
NCT01526889 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Indicators of Uveitis
NCT00089739 ·Status: COMPLETED
-
Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids
NCT00846625 ·Status: WITHDRAWN ·Phase: PHASE2
-
Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis
NCT02482129 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis
NCT05105347 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
NCT00349739 ·Status: NO_LONGER_AVAILABLE
-
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
NCT07285070 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy Study of Lucentis in the Treatment of Retinoblastoma
NCT01899066 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
NCT02764697 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis
NCT01327664 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
NCT01032915 ·Status: TERMINATED ·Phase: PHASE3